Sunday, 2nd of December 2018 |
Oral fexinidazole for human African trypanosomiasis
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30019-9/fulltext
Human African trypanosomiasis caused by Trypanosoma brucei gambiense (g-HAT) is transmitted to human beings by tsetse flies in western and central Africa. Human beings are the only significant reservoir of the protozoan parasite, and disease control is focused on the detection and treatment of infected individuals, with or without vector control.
This article is available free of charge.
Simply log in to access the full article, or register for free if you do not yet have a username and password.
Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
40914711 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |